PUMA, ADRIANA
 Distribuzione geografica
Continente #
NA - Nord America 217
EU - Europa 125
AS - Asia 26
AF - Africa 24
SA - Sud America 1
Totale 393
Nazione #
US - Stati Uniti d'America 215
IE - Irlanda 44
IT - Italia 36
SN - Senegal 15
CN - Cina 12
DE - Germania 11
CI - Costa d'Avorio 9
RU - Federazione Russa 8
GB - Regno Unito 6
SE - Svezia 5
BE - Belgio 4
IN - India 4
NO - Norvegia 3
UZ - Uzbekistan 3
CA - Canada 2
CH - Svizzera 2
HK - Hong Kong 2
PL - Polonia 2
TR - Turchia 2
BR - Brasile 1
ES - Italia 1
FR - Francia 1
IL - Israele 1
JP - Giappone 1
LB - Libano 1
LU - Lussemburgo 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 393
Città #
Chandler 97
Dublin 44
Dakar 15
Ashburn 13
Catania 13
Andover 11
Cambridge 11
Lawrence 11
Abidjan 9
Grafing 8
Des Moines 6
Brussels 4
Nanjing 4
Pune 4
Wilmington 4
Beijing 3
Edinburgh 3
Fantina 3
Hanover 3
Oslo 3
Saint Petersburg 3
Houston 2
Jiaxing 2
London 2
Palermo 2
Santa Venerina 2
Boardman 1
Bratislava 1
Chicago 1
Fairfield 1
Hebei 1
Kocaeli 1
Luxembourg 1
Madrid 1
Manchester 1
Mascali 1
Montreal 1
Moscow 1
Nanchang 1
Polska 1
Redmond 1
Redwood City 1
São Paulo 1
Tel Aviv 1
Tokyo 1
Toronto 1
Woodbridge 1
Zhengzhou 1
Totale 304
Nome #
ABL1-Directed Inhibitors for CML: Efficacy, Resistance and Future Perspectives 47
B-ALL relapses after autologous stem cell transplantation associated with a shift from e1a2 to e14a2 BCR-ABL transcripts: A case report 46
Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 Bcr-Abl1 Fusion Transcript: A Case Report 44
Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22) 40
Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report 40
A novel system for semiautomatic sample processing in chronic myeloid leukaemia: Increasing throughput without impacting on molecular monitoring at time of sars-cov-2 pandemic 39
Colony-forming cell assay detecting the co-expression of JAK2 V617F and BCR-ABL1 in the same clone: A case report 39
Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts 36
Opportunities and challenges of liquid biopsy in thyroid cancer 34
Targeting BCL-2 as a therapeutic strategy for primary p210BCR-ABL1-positive B-ALL cells 30
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma 29
Totale 424
Categoria #
all - tutte 1.687
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.687


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193 0 0 0 0 0 0 0 0 0 2 0 1
2019/202035 11 0 1 1 2 0 0 1 0 1 7 11
2020/202128 2 0 2 5 7 0 0 1 9 1 0 1
2021/202278 0 13 5 1 19 2 11 3 2 0 2 20
2022/2023235 12 23 7 33 11 37 0 49 46 3 10 4
2023/202445 6 21 1 1 5 11 0 0 0 0 0 0
Totale 424